The Effects of Muscle Training in Coronary Artery Patients With Metabolic Syndrome
The Effects of Peripheral and Respiratory Muscle Training in Coronary Artery Patients With Metabolic Syndrome: A Randomized, Prospective, Double-Blind and Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
The aim of this study is to investigate the effects of peripheral and respiratory muscle training on respiratory muscle strength, respiratory functions, exercise capacity and quality of life in coronary artery patients with metabolic syndrome. Prospectively, randomly, double-blind, and controlled study. Stable coronary artery patients with metabolic syndrome will be included to the study from the Istanbul University Cardiology Institute clinic. Patients will be randomized into 3 groups; Neuromuscular Electrical Stimulation (NMES) and Peripheral Muscle Training Group (n: 20): 3 days per week for 6 weeks duration. Peripheral Muscle Training will be applied by elastic band and Proprioceptive Neuromuscular Facilitation three times per week for 6 weeks.Inspirator Muscle Training (IMT) and peripheral muscle training Group (n: 20): IMT will be applied 7 days per week, twice a day for 15 minutes. The program will continue for 6 weeks duration under weekly control of the investigator. Training intensity will set at 30% of the maximum inspiratory pressure.Peripheral Muscle Training will be applied by elastic band and Proprioceptive Neuromuscular Facilitation three times per week for 6 weeks. Peripheral Muscle Training Group (n: 20): Exercise will be applied by elastic band and Proprioceptive Neuromuscular Facilitation three times per week for 6 weeks.Parameters will be recorded before and after training. Evaluation parameters:Demographic and anthropometric measurements, respiratory function test,respiratory muscle strength,dyspnea, peripheral muscle strength, 6 minutes walking test, physical activity, quality of life, depression, sleep quality and laboratory evaluation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 14, 2018
CompletedStudy Start
First participant enrolled
April 15, 2018
CompletedFirst Posted
Study publicly available on registry
May 14, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2018
CompletedJanuary 29, 2019
September 1, 2018
8 months
April 14, 2018
January 26, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Maximum Inspiratory Pressure (MIP)
Change from baseline Maximum Inspiratory Pressure (MIP) at 6 weeks. Respiratory muscle strength will be measured according to the portable, electronic intraoral pressure measuring device (MicroRPM, Micro Medical UK), American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria. The most commonly used method for evaluating respiratory muscles is MIP measurement is a non-invasive technique.
Baseline and 6 weeks
Maximum Expiratory Pressure (MEP)
Change from baseline Maximum Expiratory Pressure (MEP) at 6 weeks. Respiratory muscle strength will be measured according to the portable, electronic intraoral pressure measuring device (MicroRPM, Micro Medical UK), American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria. The most commonly used method for evaluating respiratory muscles is MEP measurement is a non-invasive technique.
Baseline and 6 weeks
Functional capacity
Change from baseline functional capacity test at 6 weeks. Functional capacity will be assessed by the 6 minute walking test. The test will be performed according to American Thoracic Society (ATS) criteria. Patients will be allowed to rest for 10 minutes before the test. Heart rate, blood pressure, respiratory frequency, oxygen saturation, fatigue and dyspnea perception will be recorded before and after the test. Walking distance will be calculated.
Baseline and 6 weeks
Secondary Outcomes (27)
Forced Vital Capacity (FVC)
Baseline and 6 weeks
Forced Expiratory Volume 1 second (FEV1)
Baseline and 6 weeks
Forced Expiratory Volume 1 second / Forced Vital Capacity (FEV1 / FVC)
Baseline and 6 weeks
Forced Expiratory flow from between 25% to 75% of Vital Capacity (FMF 25-75)
Baseline and 6 weeks
Peak flow rate (PEF)
Baseline and 6 weeks
- +22 more secondary outcomes
Study Arms (3)
NMES and Peripheral Muscle Training
EXPERIMENTALNeuromuscular Electrical Stimulation (NMES) and Peripheral Muscle Training NMES frequency will be 30 Hertz and the application time will be 30 minutes.Treatment will be programmed for 3 days per week. Peripheral Muscle Training will be applied by elastic band and Proprioceptive Neuromuscular Facilitation 3 times per week.The program will continue for 6 weeks.
IMT and Peripheral Muscle Training
EXPERIMENTALInspirator Muscle Training (IMT) and Peripheral Muscle Training IMT will be applied 7 days per week, twice a day for 15 minutes. Peripheral Muscle Training will be applied by elastic band and Proprioceptive Neuromuscular Facilitation 3 times per week. The program will continue for 6 weeks.
Peripheral Muscle Training
EXPERIMENTALPeripheral Muscle Training Peripheral Muscle Training will be applied by elastic band and Proprioceptive Neuromuscular Facilitation 3 times per week.The program will continue for 6 weeks.
Interventions
Neuromuscular Electrical Stimulation(NMES) to rectus abdominis will be applied using 4 carbon silicon electrode. In the first sessions, patients ECG will be checked. Patients will be in semi-fowler position (30º),with their lower limbs to be in extension and upper limbs at their sides. The NMES frequency will be at 30 Hertz and the application time will be 30 minutes. Treatment will be programmed for 3 days per week. The patients will coordinate their breath (inspiration) with the contraction which will be generated by the electrical current. The program will continue for 6 weeks.
Inspirator Muscle Training(IMT) will be applied 7 days per week, twice a day for 15 minutes. The program will continue for 6 weeks duration under weekly control of the investigator.Training intensity will set at 30% of the maximum inspiratory pressure.
Peripheral Muscle Training will be applied by elastic band and Proprioceptive Neuromuscular Facilitation 3 times per week.The program will continue for 6 weeks.
Eligibility Criteria
You may qualify if:
- Stable coronary artery disease with metabolic syndrome diagnosis
- The ejection fraction(EF) = % 40 and EF \>% 40,
- Participation to the study will be in a voluntary basis
You may not qualify if:
- Over 80 years,
- EF \<40% or New York Heart Association (NYHA) class III-IV
- Chronic obstructive pulmonary disease (COPD) and respiratory tract infection,
- Documented diagnosis of pulmonary, neurological,orthopedic, renal, hepatic, gastrointestinal, endocrine, oncologic
- New or suspected thromboembolic events
- Severe refractory hypertension
- Acute myocardial infarction and pulmonary edema in the last 6 months,
- Coronary artery revascularization attempts (percutaneous transluminal coronary angioplasty and coronary artery bypass surgery) and previous valve surgery in the last 6 months,
- Cardiac pacemaker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Istanbul Medipol University Hospitallead
- Istanbul Universitycollaborator
Study Sites (1)
Kıymet Muammer
Istanbul, Fatih/Istanbul, 34096, Turkey (Türkiye)
Related Publications (1)
Muammer K, Mutluay F, Demir R, Ozkan AA. Effects of peripheral and different inspiratory muscle training methods in coronary artery disease patients with metabolic syndrome: A randomized-controlled trial. Respir Med. 2020 Oct;172:106119. doi: 10.1016/j.rmed.2020.106119. Epub 2020 Aug 22.
PMID: 32877886DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kıymet Muammer, MSc PT
Istanbul University Cardiology Institute, Department of Physiotherapy and Rehabilitation
- STUDY DIRECTOR
Fatma Karantay Mutluay, Professor
Medipol University, Health Sciences Faculty, Physiotherapy and Rehabilitation
- STUDY CHAIR
Rengin Demir, Professor
Istanbul University Cardiology Institute, Department of Physiotherapy and Rehabilitation,
- STUDY CHAIR
Alev Arat Özkan, Professor
Istanbul University Cardiology Institute,Catheter Laboratory
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 14, 2018
First Posted
May 14, 2018
Study Start
April 15, 2018
Primary Completion
November 30, 2018
Study Completion
December 30, 2018
Last Updated
January 29, 2019
Record last verified: 2018-09